Aptargroup Stock News

AptarGroup with ticker code (ATR) now have 7 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 167 and 125 and has a mean target at 144.71. With the stocks previous close at 116.87 this would imply there is a potential upside of 23.8%. The 50 day MA is 118.1 and the 200 day MA is 129.03. The market cap for the company is $7,931m. Find out more information at: https://www.aptar.com [stock_market_widget type="chart" template="basic" color="green" assets=ATR" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $9,820m based on the market concensus. AptarGroup provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions.

AptarGroup, Inc. (NYSE: ATR ), a global leader in drug delivery, consumer product dispensing and active material science solutions, has again been named one of Barron''s 100 Most Sustainable Companies . Aptar is ranked number 70 for 2022 and this marks the fourth consecutive year Aptar has been included on Barron''s esteemed list. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220221005231/en/ Logo: Reprinted with permission from Barron''s. "We are proud to once again be named one of Barron''s 100 Most Sustainable Companies due to our continued progress in key sustainability areas such as managing our suppliers and water risk," said Stephan Tanda, Aptar President and CEO. "We are committed to evolving our business Full story available on Benzinga.com

SON vs. ATR: Which Stock Is the Better Value Option?

AptarGroup's (ATR) fourth-quarter 2021 top line improves on solid performance across all segments.

AptarGroup Inc. (ATR) CEO Stephan Tanda on Q4 2021 Results - Earnings Call Transcript

AptarGroup (ATR) delivered earnings and revenue surprises of 1.09% and 1.93%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

AptarGroup press release (ATR): Q4 Non-GAAP EPS of $0.93 beats by $0.02.Revenue of $814M (+8.6% Y/Y) beats by $29.32M.

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, today reported fourth quarter and annual results for 2021. Fourth Quarter 2021 Summary Strong top line growth across each segment resulted in reported sales up 9% and core sales (excluding currency effects and acquisitions) up 10% Reported earnings per share increased 8% to $0.85 Adjusted earnings per share (excluding

AptarGroup (ATR) delivered earnings and revenue surprises of 1.09% and 1.93%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

AptarGroup (NYSE:ATR) is scheduled to announce Q4 earnings results on Thursday, February 17th, after market close.The consensus EPS Estimate is $0.91 (-1.1% Y/Y) and the consensus…

Aptargroup Inc. (ATR) shares closed today at 1.9% above its 52 week low of $112.01, giving the company a market cap of $7B. The stock is currently down 6.5% year-to-date, down 20.2% over the past 12 months, and up 66.2% over the past five years. This week, the Dow Jones Industrial Average fell 1.2%, and the S&P 500 fell 1.1%. Trading Activity Trading volume this week was 24.9% lower than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 0.6. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Materials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 4205.4% The company's stock price performance over the past 12 months lags the peer average by -250.0% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 166.5% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.